Patent · US Active

Anti-leishmanial compound and anti-leishmanial drug

US8809555B2 · kind B2 · utility

0Cited by
1References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 13, 2011
Grant dateAug 19, 2014
Priority date—
Expiry dateOct 13, 2031

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided is an anti-leishmanial compound represented by formula (1):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.